Product Brochure: Fill & Download for Free

Global Pediatric Catheters Market Is Expected To Reach US$ 10,112.5 Mn by 2027The latest market report published by Credence Research, Inc. “Global Pediatric Catheters Market - Growth, Future Prospects, Competitive Analysis,2019- 2027,” the global pediatric catheters market is expected to reach from US$ 4,663.8 Mn in 2018 to US$ 10,112.5 Mn by 2027 expanding at a CAGR of 9.0% from 2019 to 2027.Pediatric Catheters Market, Size, Share, Trend And Forecast To 2026Market InsightsAccording to the statistics provided by World Health Organization (WHO), every year approximately 303,000 newborn babies die within 4 weeks of their birth due to congenital abnormalities. Several factors are responsible for the occurrence of congenital defects in newborn babies such as genetic, nutritional, infectious and environmental impact. Etc. the exact cause still remain unknown. Researchers are working diligently in developing pediatric catheters with excellent ergonomic features and body compatible material to minimize the risk associated with catheters and cause less discomfort to the children post surgery. In the last decade technological advancement in the operating procedures has been successful in curbing the mortality associated with congenital defects.Cardiovascular catheters are dominating the product segment for pediatric catheters market. According to the research findings of National Institute for Health (NIH), the global prevalence rate of congenital cardiovascular complications is 8 to 12 per 1000 live births. Increasing cases of drug and alcohol abuse during pregnancy increases the risk of occurrence for congenital cardiovascular disorders in the new born babies. Genetic predisposition is also related with its occurrence. Urology catheters will be growing at a rampant pace due to increasing cases of urological disease in children requiring immediate surgical intervention. Availability in different sizes for children’s belonging to different age group and excellent ergonomic design aids in healing process post surgery and enhances patient satisfaction.Download Free brochure of research report with TOC and Figures @ Sample Request - Credence ResearchNorth America with a share of 35% is the clear regional leader in global pediatric catheters market. The major feature which contributes for its dominance are rising prevalence of congenital cardiovascular complications in newborn requiring immediate surgical intervention to prolong life. Domicile of major players such as Boston Scientific Corporation, Medtronic, Plc., Johnson & Johnson etc. drive the market growth in North America region.Europe is the second largest market holding 31% share on account of supportive regulatory environment provided by European Medical Agency (EMA) and affordable reimbursement scenario for the pediatric catheters market. Asia Pacific represents 17% market share on account of increasing medical tourism and serves as a lucrative market opportunity for western giants to establish subsidiaries.Medical device manufacturers competing in the pediatric catheters market Boston Scientific Corporation, C.R.Bard, Inc., Cook Medical, Coloplast A/S, Edwards Life Science Corporation, Flexicare Medical Limited, Getinge group, Johnson & Johnson, Medtronic, Plc. and Smiths Medical.Key Market Movements:• Rising prevalence of congenital abnormalities in newborn pertaining to cardiovascular, urology and neurovascular• Favorable reimbursement scenario for pediatric catheters used in surgical intervention in children• Availability of wide range of catheters with different sizes and ergonomic design which eliminates infection and aids in healing process post surgeryTOC :Chapter 3. Pediatric Catheters Market: Dynamics and Future Outlook3.1. Market Overview3.2. Drivers3.3. Challenges3.4. Opportunities3.5. Attractive Investment Proposition, by Geography, 20183.6. Competitive Analysis: Global Pediatric Catheters Market, by Key Players, 2018Chapter 4. Global Pediatric Catheters Market, by Product4.1. Overview4.2. Cardiovascular Catheters4.3. Urology Catheters4.4. Intravenous Catheters4.5. Neurovascular Catheters4.6. Specialty CathetersDownload Free brochure of research report with TOC and Figures @ Sample Request - Credence ResearchChapter 5. Global Pediatric Catheters Market, by Geography5.1. Overview5.2. North America Pediatric Catheters Market Analysis, 2017 – 20275.2.1. North America Pediatric Catheters Market, by Product, 2017 – 2027 (US$ Mn)5.2.2. North America Pediatric Catheters Market, by Country, 2017 – 2027 (US$ Mn)5.2.2.1. U.S.5.2.2.2. Canada...Chapter 6. Company Profiles6.1. Boston Scientific Corporation6.1.1. Business Description6.1.2. Financial Information (Subject to data availability)6.1.3. Product Portfolio6.1.4. News Coverage6.2. Coloplast A/S6.3. C.R.Bard, Inc.6.4. Cook Medical6.5. Edwards Life Sciences Corporation6.6. Flexicare Medical Limited6.7. Getinge Group6.8. Johnson & Johnson6.9. Medtronic, Plc.6.10. Smiths Medical

Cardiac Rhythm Management Devices Market Expected To Reach US$ 38.56 Bn By 2026The latest market report published by Credence Research, Inc. “Cardiac Rhythm Management Devices Market Growth, Future Prospects, and Competitive Analysis, 2018 -2026” the cardiac rhythm management devices market was valued at US$ 20.88 Bn in 2017, and is expected to reach US$ 38.56 Bn by 2026, expanding at a CAGR of 6.96 % from 2018 to 2026.Download Free brochure of research report with TOC and Figures @ https://www.credenceresearch.com/sample-request/59025Market InsightsCardiac rhythm management (CRM) devices market shows a lucrative growth with constant technological advancements driving the market. Advances such as extended battery life and making devices MRI-safe has created a positive environment for the growth of this market. Additionally, enabling wireless functioning of CRM devices and providing self-monitoring options has contributed to the lucrative growth of CRM devices market.The major driver for the CRM market is the rising prevalence of arrhythmias across the globe. As per the Centers for Disease Control and Prevention (CDC) atrial fibrillation, the most common form of arrhythmia accounts for 2.7-6.1 million people in the U.S. as of 2015. The rise in adoption of unhealthy lifestyles has led to an increased risk of cardiovascular diseases, which in turn drives the growth of this market.Reporting of the adverse events such as bleeding or infections caused upon implantation of CRM devices, may restrain the market growth. Additionally, the risk of hacking of these devices from an unauthorized source could possesses a negative impact on the growth of CRM devices market. In September 2017, the FDA recalled around half million Abbott pacemakers from the market owing to its cyber security vulnerabilities. The implanted pacemakers were updated with a new software that enabled security.The CRM devices market has worldwide outreach overcoming the unmet needs of arrhythmia across the globe. North America predominates this market owing to its vast disposable income, suitable reimbursement plans pertaining to CRM devices and presence of major manufacturers across this region. According to the report, National Audit of Cardiac Rhythm Management Devices by http://heathrhythmalliance.org, the pacemaker implant rate in the U.K. is on a gradual rise, ensuring positive growth of CRM devices market in Europe.Market Competition Assessment:The cardiac rhythm management devices market comprises a vast competitive pool, with players constantly striving for advanced technology. Medtronic Plc. dominates the CRM devices market. Its newest technology of leadless pacemaker: Micra is expected to change the market dynamics in the forecast period. Other players holding strong positions in this market are Abbott Laboratories, Inc., Biotronik, Inc., Boston Scientific Corporation, Integer Holdings Corporation, LivaNova, Plc., Philips Healthcare Informatics, Inc. & ZOLL Medical Corporation.Key Market Movements:Rise in adoption of unhealthy lifestyles has increased the risk for cardiovascular diseases thus leading to an increase in demand for CRM devicesEnhancement of existing technologies and the emergence of innovative devices drive the market providing remunerative growthStringent regulatory approval processes for CRM devices could restrain the growth of this marketTOC:Chapter 3. Global Cardiac Rhythm Management Devices Market: Dynamics and Future Outlook3.1. Market Overview3.2. Markey Dynamics3.2.1. Drivers3.2.2. Challenges3.2.3. Opportunities3.3. Attractive Investment Proposition, by Geography, 20173.4. Major Agreements, Partnerships and Collaborations3.5. Competitive Landscape, by Key Players, 2017Chapter 4. Global Cardiac Rhythm Management Devices Market, by Product Type, 2016-2026 (US$ Bn)4.1. Overview4.2. Pacemakers4.2.1. Single chamber pacemakers4.2.2. Dual chamber pacemakers4.3. Defibrillators4.3.1. Internal defibrillators4.3.1.1. Transvenous implantable cardioverter defibrillator4.3.1.2. Subcutaneous implantable cardioverter defibrillator4.3.2. External defibrillators4.4. Cardiac resynchronization therapy4.4.1. Cardiac resynchronization therapy – pacemakers4.4.2. Cardiac resynchronization therapy- defibrillators4.5. Accessories4.5.1. Pacing leads4.5.2. Defibrillation leadsChapter 5. Global Cardiac Rhythm Management Devices Market, by Geography, 2016-2026 (US$ Bn)5.1. Overview5.2. North America Cardiac Rhythm Management Devices Market Analysis, 2016-2026 (US$ Bn)5.2.1. North America Cardiac Rhythm Management Devices Market, by Product Type, 2016-2026 (US$ Bn)5.2.2. North America Cardiac Rhythm Management Devices Market, by Country, 2016-2026 (US$ Bn)5.2.2.1. U.S.5.2.2.2. Canada5.3. Europe Cardiac Rhythm Management Devices Market Analysis, 2016-2026 (US$ Bn)5.3.1. Europe Cardiac Rhythm Management Devices Market, by Product Type, 2016-2026 (US$ Bn)5.3.2. Europe Cardiac Rhythm Management Devices Market, by Country, 2016-2026 (US$ Bn)5.3.2.1. U.K.5.3.2.2. Germany5.3.2.3. Rest of Europe5.4. Asia Pacific Cardiac Rhythm Management Devices Market Analysis, 2016-2026 (US$ Bn)5.4.1. Asia Pacific Cardiac Rhythm Management Devices Market, by Product Type, 2016-2026 (US$ Bn)5.4.2. Asia Pacific Cardiac Rhythm Management Devices Market, by Country, 2016-2026 (US$ Bn)5.4.2.1. Japan5.4.2.2. China5.4.2.3. Rest of APAC5.5. Latin America Cardiac Rhythm Management Devices Market Analysis, 2016-2026 (US$ Bn)5.5.1. Latin America Cardiac Rhythm Management Devices Market, by Product Type, 2016-2026 (US$ Bn)5.5.2. Latin America Cardiac Rhythm Management Devices Market, by Country, 2016-2026 (US$ Bn)...Chapter 6. Company Profiles6.1. Abbott Laboratories Inc.6.1.1. Business Description6.1.2. Financial Information (Subject to data availability)6.1.3. Product Portfolio6.1.4. Key Developments6.2. Biotronik, Inc.6.3. Boston Scientific Corporation6.4. Integer Holdings Corporation6.5. LivaNova, Plc.6.6. Medtronic Plc. ...Download Free brochure of research report with TOC and Figures @ https://www.credenceresearch.com/sample-request/59025

The latest market report published by Credence Research, Inc. “Neurovascular Guidewires Market: Growth, Future Prospects, and Competitive Analysis, 2018 - 2026” the global neurovascular guidewires market was valued at US$ 265.4 Mn in 2017 and expected to reach US$ 394.4 Mn by 2026 at a CAGR of 4.5% during the forecast period from 2018 to 2026.Market InsightsThe global neurovascular guidewires market shows dynamic growth during the forecast period from 2018 to 2026. Neurovascular guidewires support in the treatment of numerous disorders related to heart, kidney, liver and others. Growing geriatric population, advancement in guidewire technology, and demand for minimally invasive procedures are major factors driving the market growth.Heart related disorders or surgical procedures in the application segment holds the major share in the neurovascular guidewires market in 2018. Increase in demand for advanced neurovascular guidewires with enhanced lubrication, simple & easy insertion, and very less patient discomfort has generated a productive opportunity for research and development in the global market.Growing incidences of cerebral arteriovenous malformations and aneurysms mainly in the elderly population will drive the growth of the market. Additionally, upsurge in interventional diagnostic procedures in hospitals, flow in demand for minimally invasive surgical procedures, and satisfactory reimbursement structure will further spur revenue growth during the forecast period. However, high costs of advanced devices, burden of cardiovascular diseases with very fewer treatment options, lack of skilled professionals, less awareness and unstructured reimbursement scenario are factors limiting the market growth during the forecast period.Download Free brochure of research report with TOC and Figures @ https://www.credenceresearch.com/sample-request/59680The neurovascular guidewires market in North America is witnessing stable growth due to the presence of multispecialty clinics & hospitals, neurovascular centers, and the availability of top quality treatment options. Additionally, the remarkable adoption of wrapped guidewires and the huge presence of neurovascular medical device manufacturers in the U.S. will drive the market growth globally.Key Market Movements:Globally, the neurovascular guidewires market remains to exhibit a lucrative growth with a CAGR of 4.5 % for the period from 2018 to 2026Based on the material type, the nitinol (nickel- titanium alloy) segment shows lucrative growth with increasing applications in the end user industryIncreasing number of hospitals, availability of branded products with enhanced applications, and growing healthcare expenditure in the emerging nations will further drive the growth of the neurovascular guidewires market globallyMajor players in this vertical are Stryker Corporation, Cardinal Health, Inc., Boston Scientific Corporation, Cook Medical Incorporated, Medtronic, Inc., Abbott Laboratories, Cordis Corp., ASAHI INTECC CO., LTD., St. Jude Medical, Inc., Lepu Medical Technology (Beijing) Co., Ltd., Terumo Medical Corporation, Integra LifeSciences Corporation, Conmed Corporation and othersTOC :Chapter 1. PrefaceChapter 2. Executive SummaryChapter 3. Global Neurovascular Guidewires Market: Market Dynamics and Future OutlookChapter 4. Global Neurovascular Guidewires Market, by Type, 2016 – 2026 (US$ Mn)Chapter 5. Global Neurovascular Guidewires Market, by Material Type, 2016 – 2026 (US$ Mn)...Download Free brochure of research report with TOC and Figures @ https://www.credenceresearch.com/sample-request/59680Chapter 9. Company Profiles9.1. Stryker Corporation9.1.1. Business Description9.1.2. Financial Information (Subject to data availability)9.1.3. Product Portfolio9.1.4. Key Developments9.2. Cardinal Health, Inc.9.3. Boston Scientific Corporation9.4. Cook Medical Incorporated9.5. Medtronic, Inc.9.6. Abbott Laboratories9.7. Cordis Corp.9.8. ASAHI INTECC CO., LTD.9.9. St. Jude Medical9.10. Lepu Medical Technology (Beijing) Co., Ltd.9.11. Terumo Medical Corporation9.12. Integra LifeSciences Corporation9.13. Conmed Corporation...